Want to see TBPH full AI Analyst Report?
Theravance Biopharma (TBPH) Ownership Overview
24.05% Insiders
9.96% Mutual Funds
0.95% Other Institutional Investors
12.43% ETFs
52.61% Public Companies and
Individual Investors
The ownership structure of Theravance Biopharma (TBPH) stock is a mix of institutional, retail, and individual investors. Approximately 23.34% of the company’s stock is owned by Institutional Investors, 24.05% is owned by Insiders, and 52.61% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 08, 2026 | xxxxxxxxxxxxx | $119390 | |
Jul 01, 2026 | xxxxxxxxxxxxx | $5790093 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $807264 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $488880 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,167,489 | Insider | 17.69% | 155,022,239 | |
| 2,368,597 | Institution | 4.57% | 40,052,975 | |
| 2,128,501 | Institution | 4.11% | 35,992,952 | |
| 1,747,023 | Insider | 3.37% | 29,542,159 | |
| 1,738,405 | Institution | 3.35% | 29,396,429 | |
| 626,349 | Institution | 1.21% | 10,591,562 | |
| 520,952 | Institution | 1.01% | 8,809,298 | |
| 497,397 | Institution | 0.96% | 8,410,983 | |
| 464,507 | Institution | 0.90% | 7,854,813 | |
| 380,115 | Institution | 0.73% | 6,427,745 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,738,405 | Institution | 3.35% | 29,396,429 | |
| 626,349 | Institution | 1.21% | 10,591,562 | |
| 520,952 | Institution | 1.01% | 8,809,298 | |
| 497,397 | Institution | 0.96% | 8,410,983 | |
| 380,115 | Institution | 0.73% | 6,427,745 | |
| 224,114 | Institution | 0.43% | 3,789,768 | |
| 223,820 | Institution | 0.43% | 3,784,796 | |
| 199,018 | Institution | 0.38% | 3,365,394 | |
| 114,278 | Institution | 0.22% | 1,932,441 | |
| 105,566 | Institution | 0.20% | 1,785,121 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,295,682 | Institution | 2.50% | 22,026,594 | |
| 1,029,505 | Institution | 1.99% | 17,429,520 | |
| 435,648 | Institution | 0.84% | 7,406,016 | |
| 351,815 | Institution | 0.68% | 5,956,228 | |
| 304,763 | Institution | 0.59% | 5,159,638 | |
| 279,027 | Institution | 0.54% | 4,723,927 | |
| 232,191 | Institution | 0.45% | 3,947,247 | |
| 177,220 | Institution | 0.34% | 3,000,335 | |
| 164,241 | Institution | 0.32% | 2,637,710 | |
| 141,775 | Institution | 0.27% | 2,400,251 |
FAQ
Who Owns Theravance Biopharma (TBPH)?
According to the latest TipRanks data, approximately 0.95% of the company's stock is held by institutional investors, 24.05% is held by insiders, and 52.61% is held by retail investors.
What percentage of Theravance Biopharma (TBPH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.95% of Theravance Biopharma (TBPH) stock is held by institutional investors.
What percentage of Theravance Biopharma (TBPH) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.61% of Theravance Biopharma (TBPH) stock is held by retail investors.
Who owns the most shares of Theravance Biopharma (TBPH)?
Eli Samaha owns the most shares of Theravance Biopharma (TBPH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.